Motiva Implants® (Establishment Labs Holdings Inc., NY, USA) contains a\nRFID micro transponder RFID(RT) (RT = registered trademark) known as Q\nInside Safety Technology which provides an added safety feature embedded\nin the shell of the Motiva breast implant [1] [2]. Because this RFID micro\ntransponder has Ferric components, a concern over breast MRI imaging susceptibility\nartifact has arisen. Among breast images, a single high risk breast\ncancer patient was imaged at our institution (January 2018). All breast imaging\nmodalities were used to determine if this high risk patient had a recurrence\nof her cancer or any new breast cancer. The MRI showed a susceptibility\nartifact on the posterior margin of the implant but breast ultrasound\nshowed no abnormalities in the area of the susceptibility artifact. By using\nhigh risk screening including Mammography, Tomosynthesis, Breast Ultrasound\nand Breast MRI, an adequate survey of the high risk patient was completed\n[3]. Our high risk clinic examined the patient and the imaging results\nand came to the following conclusion: This patient showed no evidence of recurrent\ncancer and no new masses were identified. The conclusion was BIRADS\n2 benign: normal findings post-mastectomy and implants. Recommendation\nwas for routine high risk screening at yearly interval.
Loading....